Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LNSR Stock Forecast 2026-2027
$5.64
Current Price
$68.27M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to LNSR Price Targets
+77.3%
To High Target of $10.00
+50.7%
To Median Target of $8.50
+24.1%
To Low Target of $7.00
LNSR Price Momentum
+0.5%
1 Week Change
+3.3%
1 Month Change
-59.5%
1 Year Change
-51.5%
Year-to-Date Change
-60.6%
From 52W High of $14.31
+11.5%
From 52W Low of $5.06
📊 TOP ANALYST CALLS
Did LNSR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if LENSAR is one of their latest high-conviction picks.
Latest LNSR Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, LNSR has a bullish consensus with a median price target of $8.50 (ranging from $7.00 to $10.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $5.64, the median forecast implies a 50.7% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ryan Zimmerman at BTIG, projecting a 77.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LNSR Analyst Ratings
2
Buy
0
Hold
0
Sell
LNSR Price Target Range
Low
$7.00
Average
$8.50
High
$10.00
Current: $5.64
Latest LNSR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LNSR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 18, 2026 | BTIG | Ryan Zimmerman | Buy | Upgrade | $10.00 |
| Mar 24, 2025 | Lake Street | Frank Takkinen | Hold | Downgrade | $15.00 |
| Feb 28, 2025 | Lake Street | Frank Takkinen | Buy | Maintains | $16.00 |
| Mar 19, 2024 | Lake Street | Buy | Initiates | $8.00 | |
| Nov 22, 2021 | BTIG | Ryan Zimmerman | Buy | Initiates | $15.00 |
| Feb 24, 2021 | SVB Leerink | Outperform | Initiates | $N/A |
LENSAR, Inc. (LNSR) Competitors
The following stocks are similar to LENSAR based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LENSAR, Inc. (LNSR) Financial Data
LENSAR, Inc. has a market capitalization of $68.27M with a P/E ratio of -2.0x. The company generates $58.44M in trailing twelve-month revenue with a -58.7% profit margin.
Revenue growth is -4.2% quarter-over-quarter, while maintaining an operating margin of -116.0% and return on equity of -1,069.4%.
Valuation Metrics
Market Cap
$68.27M
Enterprise Value
$61.80M
P/E Ratio
-2.0x
PEG Ratio
0.0x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
-4.2%
Gross Margin
+43.3%
Operating Margin
-116.0%
Net Margin
-58.7%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+26.3%
Current Ratio
1.2x
Debt/Equity
-0.1x
ROE
-1,069.4%
ROA
-22.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
LENSAR, Inc. (LNSR) Business Model
About LENSAR, Inc.
What They Do
Innovative solutions for cataract surgery.
Business Model
Lensar Inc. generates revenue by selling its advanced Lensar Laser System to surgical centers and hospitals, enhancing the precision of cataract surgeries. The company focuses on continuous research and development to maintain its competitive edge in the medical technology market.
Additional Information
Headquartered in Orlando, Florida, Lensar plays a significant role in the ophthalmology sector, contributing to improved surgical standards and patient safety. The company is positioned to benefit from the growing demand for advanced eye health solutions.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
150
CEO
Mr. Nicholas T. Curtis
Country
United States
IPO Year
2020
Website
www.lensar.comLENSAR, Inc. (LNSR) Latest News & Analysis
Latest News
Quick Summary
LENSAR, Inc. will release its Q1 2026 financial results on May 8, 2026, before market open. The company specializes in robotic laser solutions for cataract treatment.
Why It Matters
LENSAR's upcoming financial results could impact stock performance, affecting investor sentiment and market positioning in the medical technology sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
LENSAR, Inc. (LNSR) held its Q4 2025 earnings call, providing insights into financial performance and future outlook. Details on revenue, growth, and operational metrics were discussed.
Why It Matters
LENSAR's Q4 2025 earnings call provides insights into financial performance, future guidance, and market trends, impacting stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
ALLY Systems placed 15 robotic cataract laser systems in Q4 2025, with a backlog of 13 systems awaiting installation as of December 31, 2025.
Why It Matters
The placement of 15 ALLY Systems and a backlog of 13 indicate strong demand, suggesting potential revenue growth and market expansion for the company in the medical technology sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
In March 2025, Alcon announced its agreement to acquire a laser solutions company for $14.00 per share, totaling an implied value of about $356 million.
Why It Matters
Alcon's acquisition at $14 per share signals confidence in growth potential, impacting stock valuation and investor sentiment regarding future profitability.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
LENSAR, Inc. announced the termination of its merger agreement with Alcon Research, LLC, as of March 16, 2026.
Why It Matters
LENSAR's termination of the merger with Alcon may impact its market position and future growth potential, affecting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
LENSAR, Inc. announced an update regarding its pending acquisition by Alcon Research, LLC, as part of its focus on advanced robotic laser solutions for cataract treatment.
Why It Matters
LENSAR's pending acquisition by Alcon could impact market confidence, stock valuation, and future growth potential, influencing investor sentiment and decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LNSR Stock
What is LENSAR, Inc.'s (LNSR) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, LENSAR, Inc. (LNSR) has a median price target of $8.50. The highest price target is $10.00 and the lowest is $7.00.
Is LNSR stock a good investment in 2026?
According to current analyst ratings, LNSR has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.64. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LNSR stock?
Wall Street analysts predict LNSR stock could reach $8.50 in the next 12 months. This represents a 50.7% increase from the current price of $5.64. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is LENSAR, Inc.'s business model?
Lensar Inc. generates revenue by selling its advanced Lensar Laser System to surgical centers and hospitals, enhancing the precision of cataract surgeries. The company focuses on continuous research and development to maintain its competitive edge in the medical technology market.
What is the highest forecasted price for LNSR LENSAR, Inc.?
The highest price target for LNSR is $10.00 from Ryan Zimmerman at BTIG, which represents a 77.3% increase from the current price of $5.64.
What is the lowest forecasted price for LNSR LENSAR, Inc.?
The lowest price target for LNSR is $7.00 from at , which represents a 24.1% increase from the current price of $5.64.
What is the overall LNSR consensus from analysts for LENSAR, Inc.?
The overall analyst consensus for LNSR is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $8.50.
How accurate are LNSR stock price projections?
Stock price projections, including those for LENSAR, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 9, 2026 9:48 AM UTC